ArticleBlood advances2026

Targeting Aurora kinase A to prevent GVHD and relapse after myeloablative allogeneic hematopoietic cell transplantation.

Shernan G Holtan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.